Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11191739 Bupropion as a modulator of drug activity

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Herriot Tabuteau0

Date of Patent

December 7, 2021

0

Patent Application Number

171921920

Date Filed

March 4, 2021

0

Patent Citations

US Patent 11123344 Bupropion as a modulator of drug activity

Patent Citations Received

US Patent 12109178 Bupropion as a modulator of drug activity

0

US Patent 11969421 Bupropion as a modulator of drug activity

0

US Patent 11986444 Treatment of poor metabolizers of dextromethorphan with a combination of bupropion and dextromethorphan

0

0

US Patent 11478468 Bupropion as a modulator of drug activity

US Patent 11497721 Bupropion as a modulator of drug activity

US Patent 11510918 Bupropion as a modulator of drug activity

US Patent 11517542 Bupropion as a modulator of drug activity

...

Patent Primary Examiner

Yevgeny Valenrod

0

Patent abstract

Dosage forms, drug delivery systems, and methods related to sustained release of dextromethorphan or improved therapeutic effects are disclosed. Typically, bupropion or a related compound is orally administered to a human being to be treated with, or being treated with, dextromethorphan.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11191739 Bupropion as a modulator of drug activity

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool